<html>
<head>PUBMED IDs for SERINC5</head>
<body bgcolor='#C5F0F2'><h1>SERINC5</h1><a href='https://pubmed.ncbi.nlm.nih.gov/26416734/'>HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.</a> March 31  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26416733/'>SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.</a> March 31  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26703715/'>Spotlight on HIV-1 Nef: SERINC3 and SERINC5 Identified as Restriction Factors Antagonized by the Pathogenesis Factor.</a> September 30  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27356902/'>The Evolutionary Histories of Antiretroviral Proteins SERINC3 and SERINC5 Do Not Support an Evolutionary Arms Race in Primates.</a> May 10  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27681140/'>The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.</a> September 30  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27928004/'>Effect of HIV-1 Env on SERINC5 Antagonism.</a> December 9  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28179429/'>SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.</a> February 10  2017<br></body></html>
